BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast
,
Avian flu virus
,
Prozac
,
rs6983267
,
EGFR
,
Apoptosis
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
toll-like receptor-2
Summary
General Info
Curated Studies
Most Correlated Studies
CD11b+ Cd11c- cells from spleens of NOD mice with or without IDD3 KO and peptidoglycan stimulation
Wild-type and p38a-knockout dendritic cells stimulated with Pam3CSK4
Spleens of Streptococcus suis (P1/7 and SC84 strains) infected TLR2 knockouts
Dendritic cells matured with talctoferrin alfa or TNF and IL1B
Gene expression profile of normal and calcified stenotic human aortic valves
Explore Curated Studies Results
Literature
Most Relevant Literature
Structure based design and synthesis of novel Toll-like Receptor 2 (TLR 2) lipid antagonists.
Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
TLR2 mediates autophagy through ERK signaling pathway in Chlamydia psittaci CPSIT_p7 protein-stimula…
TLR2-mediated innate immune priming boosts lung anti-viral immunity.
Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.
A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll…
Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis
Plasmacytoid Dendritic Cells and Toll Like Receptor 8 in Systemic Sclerosis
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ